Literature DB >> 7163779

Microbiological and immunological studies in a case of human melioidosis diagnosed in Denmark.

A Bremmelgaard, I Bygbjerg, N Høiby.   

Abstract

The first case of melioidosis reported in Denmark was in a 64-year-old man 2 weeks after his return from a 3-week visit to Kenya. The clinical course was characterized by septicaemia and Pseudomonas pseudomallei was isolated from repeated blood cultures, urine and sputum. Transient impairment of cellular immunity was observed. During the convalescence a cell-mediated immune response against the pathogen was detected by the lymphocyte blast transformation test. Two precipitins against P. pseudomallei were detected by crossed immunoelectrophoresis; the most pronounced was directed against the common antigen of P. aeruginosa. The patient was treated with a combination of oxytetracycline, sulfamethoxazole and trimethoprim for one month, followed by sulfamethoxazole and trimethoprim for another month. The clinical response to the treatment was good. The patient had previously had recurrent pulmonary tuberculosis. The relationship of melioidosis to tuberculosis is briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7163779     DOI: 10.3109/inf.1982.14.issue-4.05

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  11 in total

1.  Reactivation of latent melioidosis.

Authors:  A B Johnson; N Ali
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

Review 2.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 3.  Melioidosis: the tip of the iceberg?

Authors:  D A Dance
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

4.  Melioidosis acquired by traveler to Nigeria.

Authors:  Alex P Salam; Nisa Khan; Henry Malnick; Dervla T D Kenna; David A B Dance; John L Klein
Journal:  Emerg Infect Dis       Date:  2011-07       Impact factor: 6.883

5.  Clinical, environmental, and serologic surveillance studies of melioidosis in Gabon, 2012-2013.

Authors:  W Joost Wiersinga; Emma Birnie; Tassili A F Weehuizen; Abraham S Alabi; Michaëla A M Huson; Robert A G Huis in 't Veld; Harry K Mabala; Gregoire K Adzoda; Yannick Raczynski-Henk; Meral Esen; Bertrand Lell; Peter G Kremsner; Caroline E Visser; Vanaporn Wuthiekanun; Sharon J Peacock; Arie van der Ende; Direk Limmathurotsakul; Martin P Grobusch
Journal:  Emerg Infect Dis       Date:  2015-01       Impact factor: 6.883

Review 6.  Melioidosis: Clinical impact and public health threat in the tropics.

Authors:  Ramar Perumal Samy; Bradley G Stiles; Gautam Sethi; Lina H K Lim
Journal:  PLoS Negl Trop Dis       Date:  2017-05-11

Review 7.  Melioidosis in Africa: Time to Uncover the True Disease Load.

Authors:  Ivo Steinmetz; Gabriel E Wagner; Estelle Kanyala; Mamadou Sawadogo; Hema Soumeya; Mekonnen Teferi; Emawayish Andargie; Biruk Yeshitela; Louise Yaba Atsé-Achi; Moussa Sanogo; Bassirou Bonfoh; Raphael Rakotozandrindrainy; Célestin Pongombo Shongo; Mick Shongoya Pongombo; Eric Kasamba Ilunga; Sabine Lichtenegger; Karoline Assig; Jürgen May; Eric Bertherat; Michael Owusu; Ellis Owusu-Dabo; Yaw Adu-Sarkodie
Journal:  Trop Med Infect Dis       Date:  2018-06-10

8.  Population-Based Estimate of Melioidosis, Kenya.

Authors:  Esther M Muthumbi; Nicola C Gordon; George Mochamah; Sammy Nyongesa; Emily Odipo; Salim Mwarumba; Neema Mturi; Anthony O Etyang; David A B Dance; J Anthony G Scott; Susan C Morpeth
Journal:  Emerg Infect Dis       Date:  2019-05       Impact factor: 6.883

9.  Human melioidosis, Malawi, 2011.

Authors:  Thembi Katangwe; Janet Purcell; Naor Bar-Zeev; Brigitte Denis; Jacqui Montgomery; Maaike Alaerts; Robert Simon Heyderman; David A B Dance; Neil Kennedy; Nicholas Feasey; Christopher Alan Moxon
Journal:  Emerg Infect Dis       Date:  2013-06       Impact factor: 6.883

10.  Melioidosis in traveler from Africa to Spain.

Authors:  María I Morosini; Carmen Quereda; Horacio Gil; Pedro Anda; María Núñez-Murga; Rafael Cantón; Rogelio López-Vélez
Journal:  Emerg Infect Dis       Date:  2013-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.